History of Lactoferrin Research: From Milk Protein to Longevity Supplement
Expert Summary
Lactoferrin's research journey spans 85 years from initial isolation to its current status as a clinically validated multifunctional bioactive protein. The field has accelerated dramatically in the past decade with human clinical trials spanning COVID-19, neonatal health, anemia, and immune aging.
Key Facts
- 1939: First isolation from bovine milk by Sorensen and Sorensen — originally termed "red protein" due to its iron-induced pink color.
- 1961: Isolation from human colostrum; characterization as a member of the transferrin family.
- 1960s–1970s: Iron-binding properties characterized; discovery of two iron-binding lobes (N-lobe and C-lobe) with independent iron coordination.
- 1987: Lactoferricin (antimicrobial peptide derived from N-terminus) identified — providing the molecular basis for lactoferrin's direct bactericidal activity.
- 1995: First papers demonstrating lactoferrin's antiviral activity (herpes simplex, CMV), establishing its role in mucosal antiviral defense.
- 2001–2005: Lactoferrin receptors on human cells (LfR1 on enterocytes and lymphocytes) characterized — explaining its immune cell activation and gut absorption mechanisms.
- 2010–2015: Major RCTs confirm lactoferrin superiority to iron salts for anemia treatment, particularly in pregnancy; gut microbiome modulation documented.
- 2020–2021: COVID-19 lactoferrin trials published; Campione et al. RCT showing significant symptom and duration reduction.
- 2022–2025: Growing body of trials evaluating lactoferrin for longevity, immune aging, and neurodegenerative disease prevention.
Recommended Products
Frequently Asked Questions
Who are the leading lactoferrin researchers today?
Key researchers include: Bo Lönnerdal (UC Davis — infant nutrition and lactoferrin mechanisms), Francesca Berlutti and Piera Valenti (Sapienza University, Rome — antiviral lactoferrin), and Elena Campione (Tor Vergata University — COVID-19 lactoferrin trials).
Scientific References
- Lönnerdal B. Human milk lactoferrin. Breastfeeding Medicine. 2013. PMID: 23631764
- Campione E et al. Lactoferrin against SARS-CoV-2. Frontiers in Pharmacology. 2021. PMID: 34220505